Ottobock SE & Co. KGaA (FRA:OBCK)

Market Cap	3.64B
Revenue (ttm)	1.66B +10.9%
Net Income	59.20M +20.9%
EPS	10.52 +17.6%
Shares Out	n/a
PE Ratio	61.56
Forward PE	20.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	263
Average Volume	473
Open	57.65
Previous Close	57.95
Day's Range	57.25 - 57.70
52-Week Range	54.15 - 76.00
Beta	n/a
RSI	39.97
Earnings Date	Mar 19, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. The company develops exo-prosthetics products, including microprocessor-controlled lower limb prosthesis systems, bionic prosthetic systems, michelangelo prosthetic hands, and liner and closure systems; temporary fittings for after accidents and injuries; ankle sprains products; fittings for partial paralysis of legs; and mechatronic orthos...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1919
• Employees: 9,256
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OBCK

Financial Performance

In 2024, Ottobock SE & Co. KGaA's revenue was 1.60 billion, an increase of 7.33% compared to the previous year's 1.50 billion. Earnings were 30.20 million, a decrease of -38.32%.